Global Hormonal Transdermal Patches Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Hormonal Transdermal Patches Industry Forecast” looks at past sales and reviews total world Hormonal Transdermal Patches sales in 2022, providing a comprehensive analysis by region and market sector of projected Hormonal Transdermal Patches sales for 2023 through 2029. With Hormonal Transdermal Patches sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hormonal Transdermal Patches industry.
This Insight Report provides a comprehensive analysis of the global Hormonal Transdermal Patches landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hormonal Transdermal Patches portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Hormonal Transdermal Patches market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hormonal Transdermal Patches and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hormonal Transdermal Patches.
The global Hormonal Transdermal Patches market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Hormonal Transdermal Patches is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Hormonal Transdermal Patches is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Hormonal Transdermal Patches is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Hormonal Transdermal Patches players cover Xulane, Twirla, Planned Parenthood, Lvye Pharma, Novartis, Bayer Healthcare Pharmaceuticals, Watson Labs, Women First Healthcare Inc and Noven, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Hormonal Transdermal Patches market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Hormonal Transdermal Patches market?
What factors are driving Hormonal Transdermal Patches market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hormonal Transdermal Patches market opportunities vary by end market size?
How does Hormonal Transdermal Patches break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Hormonal Transdermal Patches Industry Forecast” looks at past sales and reviews total world Hormonal Transdermal Patches sales in 2022, providing a comprehensive analysis by region and market sector of projected Hormonal Transdermal Patches sales for 2023 through 2029. With Hormonal Transdermal Patches sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hormonal Transdermal Patches industry.
This Insight Report provides a comprehensive analysis of the global Hormonal Transdermal Patches landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hormonal Transdermal Patches portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Hormonal Transdermal Patches market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hormonal Transdermal Patches and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hormonal Transdermal Patches.
The global Hormonal Transdermal Patches market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Hormonal Transdermal Patches is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Hormonal Transdermal Patches is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Hormonal Transdermal Patches is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Hormonal Transdermal Patches players cover Xulane, Twirla, Planned Parenthood, Lvye Pharma, Novartis, Bayer Healthcare Pharmaceuticals, Watson Labs, Women First Healthcare Inc and Noven, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Hormonal Transdermal Patches market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Contraceptive Patches
- Estradiol Patches
- Others
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Xulane
- Twirla
- Planned Parenthood
- Lvye Pharma
- Novartis
- Bayer Healthcare Pharmaceuticals
- Watson Labs
- Women First Healthcare Inc
- Noven
- AbbVie
- Lumara Health
- ANI Pharmaceuticals
What is the 10-year outlook for the global Hormonal Transdermal Patches market?
What factors are driving Hormonal Transdermal Patches market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hormonal Transdermal Patches market opportunities vary by end market size?
How does Hormonal Transdermal Patches break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hormonal Transdermal Patches Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Hormonal Transdermal Patches by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Hormonal Transdermal Patches by Country/Region, 2018, 2022 & 2029
2.2 Hormonal Transdermal Patches Segment by Type
2.2.1 Contraceptive Patches
2.2.2 Estradiol Patches
2.2.3 Others
2.3 Hormonal Transdermal Patches Sales by Type
2.3.1 Global Hormonal Transdermal Patches Sales Market Share by Type (2018-2023)
2.3.2 Global Hormonal Transdermal Patches Revenue and Market Share by Type (2018-2023)
2.3.3 Global Hormonal Transdermal Patches Sale Price by Type (2018-2023)
2.4 Hormonal Transdermal Patches Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Hormonal Transdermal Patches Sales by Application
2.5.1 Global Hormonal Transdermal Patches Sale Market Share by Application (2018-2023)
2.5.2 Global Hormonal Transdermal Patches Revenue and Market Share by Application (2018-2023)
2.5.3 Global Hormonal Transdermal Patches Sale Price by Application (2018-2023)
3 GLOBAL HORMONAL TRANSDERMAL PATCHES BY COMPANY
3.1 Global Hormonal Transdermal Patches Breakdown Data by Company
3.1.1 Global Hormonal Transdermal Patches Annual Sales by Company (2018-2023)
3.1.2 Global Hormonal Transdermal Patches Sales Market Share by Company (2018-2023)
3.2 Global Hormonal Transdermal Patches Annual Revenue by Company (2018-2023)
3.2.1 Global Hormonal Transdermal Patches Revenue by Company (2018-2023)
3.2.2 Global Hormonal Transdermal Patches Revenue Market Share by Company (2018-2023)
3.3 Global Hormonal Transdermal Patches Sale Price by Company
3.4 Key Manufacturers Hormonal Transdermal Patches Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hormonal Transdermal Patches Product Location Distribution
3.4.2 Players Hormonal Transdermal Patches Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HORMONAL TRANSDERMAL PATCHES BY GEOGRAPHIC REGION
4.1 World Historic Hormonal Transdermal Patches Market Size by Geographic Region (2018-2023)
4.1.1 Global Hormonal Transdermal Patches Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Hormonal Transdermal Patches Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Hormonal Transdermal Patches Market Size by Country/Region (2018-2023)
4.2.1 Global Hormonal Transdermal Patches Annual Sales by Country/Region (2018-2023)
4.2.2 Global Hormonal Transdermal Patches Annual Revenue by Country/Region (2018-2023)
4.3 Americas Hormonal Transdermal Patches Sales Growth
4.4 APAC Hormonal Transdermal Patches Sales Growth
4.5 Europe Hormonal Transdermal Patches Sales Growth
4.6 Middle East & Africa Hormonal Transdermal Patches Sales Growth
5 AMERICAS
5.1 Americas Hormonal Transdermal Patches Sales by Country
5.1.1 Americas Hormonal Transdermal Patches Sales by Country (2018-2023)
5.1.2 Americas Hormonal Transdermal Patches Revenue by Country (2018-2023)
5.2 Americas Hormonal Transdermal Patches Sales by Type
5.3 Americas Hormonal Transdermal Patches Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hormonal Transdermal Patches Sales by Region
6.1.1 APAC Hormonal Transdermal Patches Sales by Region (2018-2023)
6.1.2 APAC Hormonal Transdermal Patches Revenue by Region (2018-2023)
6.2 APAC Hormonal Transdermal Patches Sales by Type
6.3 APAC Hormonal Transdermal Patches Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hormonal Transdermal Patches by Country
7.1.1 Europe Hormonal Transdermal Patches Sales by Country (2018-2023)
7.1.2 Europe Hormonal Transdermal Patches Revenue by Country (2018-2023)
7.2 Europe Hormonal Transdermal Patches Sales by Type
7.3 Europe Hormonal Transdermal Patches Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hormonal Transdermal Patches by Country
8.1.1 Middle East & Africa Hormonal Transdermal Patches Sales by Country (2018-2023)
8.1.2 Middle East & Africa Hormonal Transdermal Patches Revenue by Country (2018-2023)
8.2 Middle East & Africa Hormonal Transdermal Patches Sales by Type
8.3 Middle East & Africa Hormonal Transdermal Patches Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hormonal Transdermal Patches
10.3 Manufacturing Process Analysis of Hormonal Transdermal Patches
10.4 Industry Chain Structure of Hormonal Transdermal Patches
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hormonal Transdermal Patches Distributors
11.3 Hormonal Transdermal Patches Customer
12 WORLD FORECAST REVIEW FOR HORMONAL TRANSDERMAL PATCHES BY GEOGRAPHIC REGION
12.1 Global Hormonal Transdermal Patches Market Size Forecast by Region
12.1.1 Global Hormonal Transdermal Patches Forecast by Region (2024-2029)
12.1.2 Global Hormonal Transdermal Patches Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hormonal Transdermal Patches Forecast by Type
12.7 Global Hormonal Transdermal Patches Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Xulane
13.1.1 Xulane Company Information
13.1.2 Xulane Hormonal Transdermal Patches Product Portfolios and Specifications
13.1.3 Xulane Hormonal Transdermal Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Xulane Main Business Overview
13.1.5 Xulane Latest Developments
13.2 Twirla
13.2.1 Twirla Company Information
13.2.2 Twirla Hormonal Transdermal Patches Product Portfolios and Specifications
13.2.3 Twirla Hormonal Transdermal Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Twirla Main Business Overview
13.2.5 Twirla Latest Developments
13.3 Planned Parenthood
13.3.1 Planned Parenthood Company Information
13.3.2 Planned Parenthood Hormonal Transdermal Patches Product Portfolios and Specifications
13.3.3 Planned Parenthood Hormonal Transdermal Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Planned Parenthood Main Business Overview
13.3.5 Planned Parenthood Latest Developments
13.4 Lvye Pharma
13.4.1 Lvye Pharma Company Information
13.4.2 Lvye Pharma Hormonal Transdermal Patches Product Portfolios and Specifications
13.4.3 Lvye Pharma Hormonal Transdermal Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Lvye Pharma Main Business Overview
13.4.5 Lvye Pharma Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis Hormonal Transdermal Patches Product Portfolios and Specifications
13.5.3 Novartis Hormonal Transdermal Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Bayer Healthcare Pharmaceuticals
13.6.1 Bayer Healthcare Pharmaceuticals Company Information
13.6.2 Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Product Portfolios and Specifications
13.6.3 Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bayer Healthcare Pharmaceuticals Main Business Overview
13.6.5 Bayer Healthcare Pharmaceuticals Latest Developments
13.7 Watson Labs
13.7.1 Watson Labs Company Information
13.7.2 Watson Labs Hormonal Transdermal Patches Product Portfolios and Specifications
13.7.3 Watson Labs Hormonal Transdermal Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Watson Labs Main Business Overview
13.7.5 Watson Labs Latest Developments
13.8 Women First Healthcare Inc
13.8.1 Women First Healthcare Inc Company Information
13.8.2 Women First Healthcare Inc Hormonal Transdermal Patches Product Portfolios and Specifications
13.8.3 Women First Healthcare Inc Hormonal Transdermal Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Women First Healthcare Inc Main Business Overview
13.8.5 Women First Healthcare Inc Latest Developments
13.9 Noven
13.9.1 Noven Company Information
13.9.2 Noven Hormonal Transdermal Patches Product Portfolios and Specifications
13.9.3 Noven Hormonal Transdermal Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Noven Main Business Overview
13.9.5 Noven Latest Developments
13.10 AbbVie
13.10.1 AbbVie Company Information
13.10.2 AbbVie Hormonal Transdermal Patches Product Portfolios and Specifications
13.10.3 AbbVie Hormonal Transdermal Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 AbbVie Main Business Overview
13.10.5 AbbVie Latest Developments
13.11 Lumara Health
13.11.1 Lumara Health Company Information
13.11.2 Lumara Health Hormonal Transdermal Patches Product Portfolios and Specifications
13.11.3 Lumara Health Hormonal Transdermal Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Lumara Health Main Business Overview
13.11.5 Lumara Health Latest Developments
13.12 ANI Pharmaceuticals
13.12.1 ANI Pharmaceuticals Company Information
13.12.2 ANI Pharmaceuticals Hormonal Transdermal Patches Product Portfolios and Specifications
13.12.3 ANI Pharmaceuticals Hormonal Transdermal Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 ANI Pharmaceuticals Main Business Overview
13.12.5 ANI Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hormonal Transdermal Patches Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Hormonal Transdermal Patches by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Hormonal Transdermal Patches by Country/Region, 2018, 2022 & 2029
2.2 Hormonal Transdermal Patches Segment by Type
2.2.1 Contraceptive Patches
2.2.2 Estradiol Patches
2.2.3 Others
2.3 Hormonal Transdermal Patches Sales by Type
2.3.1 Global Hormonal Transdermal Patches Sales Market Share by Type (2018-2023)
2.3.2 Global Hormonal Transdermal Patches Revenue and Market Share by Type (2018-2023)
2.3.3 Global Hormonal Transdermal Patches Sale Price by Type (2018-2023)
2.4 Hormonal Transdermal Patches Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Hormonal Transdermal Patches Sales by Application
2.5.1 Global Hormonal Transdermal Patches Sale Market Share by Application (2018-2023)
2.5.2 Global Hormonal Transdermal Patches Revenue and Market Share by Application (2018-2023)
2.5.3 Global Hormonal Transdermal Patches Sale Price by Application (2018-2023)
3 GLOBAL HORMONAL TRANSDERMAL PATCHES BY COMPANY
3.1 Global Hormonal Transdermal Patches Breakdown Data by Company
3.1.1 Global Hormonal Transdermal Patches Annual Sales by Company (2018-2023)
3.1.2 Global Hormonal Transdermal Patches Sales Market Share by Company (2018-2023)
3.2 Global Hormonal Transdermal Patches Annual Revenue by Company (2018-2023)
3.2.1 Global Hormonal Transdermal Patches Revenue by Company (2018-2023)
3.2.2 Global Hormonal Transdermal Patches Revenue Market Share by Company (2018-2023)
3.3 Global Hormonal Transdermal Patches Sale Price by Company
3.4 Key Manufacturers Hormonal Transdermal Patches Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hormonal Transdermal Patches Product Location Distribution
3.4.2 Players Hormonal Transdermal Patches Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HORMONAL TRANSDERMAL PATCHES BY GEOGRAPHIC REGION
4.1 World Historic Hormonal Transdermal Patches Market Size by Geographic Region (2018-2023)
4.1.1 Global Hormonal Transdermal Patches Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Hormonal Transdermal Patches Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Hormonal Transdermal Patches Market Size by Country/Region (2018-2023)
4.2.1 Global Hormonal Transdermal Patches Annual Sales by Country/Region (2018-2023)
4.2.2 Global Hormonal Transdermal Patches Annual Revenue by Country/Region (2018-2023)
4.3 Americas Hormonal Transdermal Patches Sales Growth
4.4 APAC Hormonal Transdermal Patches Sales Growth
4.5 Europe Hormonal Transdermal Patches Sales Growth
4.6 Middle East & Africa Hormonal Transdermal Patches Sales Growth
5 AMERICAS
5.1 Americas Hormonal Transdermal Patches Sales by Country
5.1.1 Americas Hormonal Transdermal Patches Sales by Country (2018-2023)
5.1.2 Americas Hormonal Transdermal Patches Revenue by Country (2018-2023)
5.2 Americas Hormonal Transdermal Patches Sales by Type
5.3 Americas Hormonal Transdermal Patches Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hormonal Transdermal Patches Sales by Region
6.1.1 APAC Hormonal Transdermal Patches Sales by Region (2018-2023)
6.1.2 APAC Hormonal Transdermal Patches Revenue by Region (2018-2023)
6.2 APAC Hormonal Transdermal Patches Sales by Type
6.3 APAC Hormonal Transdermal Patches Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hormonal Transdermal Patches by Country
7.1.1 Europe Hormonal Transdermal Patches Sales by Country (2018-2023)
7.1.2 Europe Hormonal Transdermal Patches Revenue by Country (2018-2023)
7.2 Europe Hormonal Transdermal Patches Sales by Type
7.3 Europe Hormonal Transdermal Patches Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hormonal Transdermal Patches by Country
8.1.1 Middle East & Africa Hormonal Transdermal Patches Sales by Country (2018-2023)
8.1.2 Middle East & Africa Hormonal Transdermal Patches Revenue by Country (2018-2023)
8.2 Middle East & Africa Hormonal Transdermal Patches Sales by Type
8.3 Middle East & Africa Hormonal Transdermal Patches Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hormonal Transdermal Patches
10.3 Manufacturing Process Analysis of Hormonal Transdermal Patches
10.4 Industry Chain Structure of Hormonal Transdermal Patches
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hormonal Transdermal Patches Distributors
11.3 Hormonal Transdermal Patches Customer
12 WORLD FORECAST REVIEW FOR HORMONAL TRANSDERMAL PATCHES BY GEOGRAPHIC REGION
12.1 Global Hormonal Transdermal Patches Market Size Forecast by Region
12.1.1 Global Hormonal Transdermal Patches Forecast by Region (2024-2029)
12.1.2 Global Hormonal Transdermal Patches Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hormonal Transdermal Patches Forecast by Type
12.7 Global Hormonal Transdermal Patches Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Xulane
13.1.1 Xulane Company Information
13.1.2 Xulane Hormonal Transdermal Patches Product Portfolios and Specifications
13.1.3 Xulane Hormonal Transdermal Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Xulane Main Business Overview
13.1.5 Xulane Latest Developments
13.2 Twirla
13.2.1 Twirla Company Information
13.2.2 Twirla Hormonal Transdermal Patches Product Portfolios and Specifications
13.2.3 Twirla Hormonal Transdermal Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Twirla Main Business Overview
13.2.5 Twirla Latest Developments
13.3 Planned Parenthood
13.3.1 Planned Parenthood Company Information
13.3.2 Planned Parenthood Hormonal Transdermal Patches Product Portfolios and Specifications
13.3.3 Planned Parenthood Hormonal Transdermal Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Planned Parenthood Main Business Overview
13.3.5 Planned Parenthood Latest Developments
13.4 Lvye Pharma
13.4.1 Lvye Pharma Company Information
13.4.2 Lvye Pharma Hormonal Transdermal Patches Product Portfolios and Specifications
13.4.3 Lvye Pharma Hormonal Transdermal Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Lvye Pharma Main Business Overview
13.4.5 Lvye Pharma Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis Hormonal Transdermal Patches Product Portfolios and Specifications
13.5.3 Novartis Hormonal Transdermal Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Bayer Healthcare Pharmaceuticals
13.6.1 Bayer Healthcare Pharmaceuticals Company Information
13.6.2 Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Product Portfolios and Specifications
13.6.3 Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bayer Healthcare Pharmaceuticals Main Business Overview
13.6.5 Bayer Healthcare Pharmaceuticals Latest Developments
13.7 Watson Labs
13.7.1 Watson Labs Company Information
13.7.2 Watson Labs Hormonal Transdermal Patches Product Portfolios and Specifications
13.7.3 Watson Labs Hormonal Transdermal Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Watson Labs Main Business Overview
13.7.5 Watson Labs Latest Developments
13.8 Women First Healthcare Inc
13.8.1 Women First Healthcare Inc Company Information
13.8.2 Women First Healthcare Inc Hormonal Transdermal Patches Product Portfolios and Specifications
13.8.3 Women First Healthcare Inc Hormonal Transdermal Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Women First Healthcare Inc Main Business Overview
13.8.5 Women First Healthcare Inc Latest Developments
13.9 Noven
13.9.1 Noven Company Information
13.9.2 Noven Hormonal Transdermal Patches Product Portfolios and Specifications
13.9.3 Noven Hormonal Transdermal Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Noven Main Business Overview
13.9.5 Noven Latest Developments
13.10 AbbVie
13.10.1 AbbVie Company Information
13.10.2 AbbVie Hormonal Transdermal Patches Product Portfolios and Specifications
13.10.3 AbbVie Hormonal Transdermal Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 AbbVie Main Business Overview
13.10.5 AbbVie Latest Developments
13.11 Lumara Health
13.11.1 Lumara Health Company Information
13.11.2 Lumara Health Hormonal Transdermal Patches Product Portfolios and Specifications
13.11.3 Lumara Health Hormonal Transdermal Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Lumara Health Main Business Overview
13.11.5 Lumara Health Latest Developments
13.12 ANI Pharmaceuticals
13.12.1 ANI Pharmaceuticals Company Information
13.12.2 ANI Pharmaceuticals Hormonal Transdermal Patches Product Portfolios and Specifications
13.12.3 ANI Pharmaceuticals Hormonal Transdermal Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 ANI Pharmaceuticals Main Business Overview
13.12.5 ANI Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hormonal Transdermal Patches Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Hormonal Transdermal Patches Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Contraceptive Patches
Table 4. Major Players of Estradiol Patches
Table 5. Major Players of Others
Table 6. Global Hormonal Transdermal Patches Sales by Type (2018-2023) & (K Units)
Table 7. Global Hormonal Transdermal Patches Sales Market Share by Type (2018-2023)
Table 8. Global Hormonal Transdermal Patches Revenue by Type (2018-2023) & ($ million)
Table 9. Global Hormonal Transdermal Patches Revenue Market Share by Type (2018-2023)
Table 10. Global Hormonal Transdermal Patches Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Hormonal Transdermal Patches Sales by Application (2018-2023) & (K Units)
Table 12. Global Hormonal Transdermal Patches Sales Market Share by Application (2018-2023)
Table 13. Global Hormonal Transdermal Patches Revenue by Application (2018-2023)
Table 14. Global Hormonal Transdermal Patches Revenue Market Share by Application (2018-2023)
Table 15. Global Hormonal Transdermal Patches Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Hormonal Transdermal Patches Sales by Company (2018-2023) & (K Units)
Table 17. Global Hormonal Transdermal Patches Sales Market Share by Company (2018-2023)
Table 18. Global Hormonal Transdermal Patches Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Hormonal Transdermal Patches Revenue Market Share by Company (2018-2023)
Table 20. Global Hormonal Transdermal Patches Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Hormonal Transdermal Patches Producing Area Distribution and Sales Area
Table 22. Players Hormonal Transdermal Patches Products Offered
Table 23. Hormonal Transdermal Patches Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Hormonal Transdermal Patches Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Hormonal Transdermal Patches Sales Market Share Geographic Region (2018-2023)
Table 28. Global Hormonal Transdermal Patches Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Hormonal Transdermal Patches Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Hormonal Transdermal Patches Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Hormonal Transdermal Patches Sales Market Share by Country/Region (2018-2023)
Table 32. Global Hormonal Transdermal Patches Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Hormonal Transdermal Patches Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Hormonal Transdermal Patches Sales by Country (2018-2023) & (K Units)
Table 35. Americas Hormonal Transdermal Patches Sales Market Share by Country (2018-2023)
Table 36. Americas Hormonal Transdermal Patches Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Hormonal Transdermal Patches Revenue Market Share by Country (2018-2023)
Table 38. Americas Hormonal Transdermal Patches Sales by Type (2018-2023) & (K Units)
Table 39. Americas Hormonal Transdermal Patches Sales by Application (2018-2023) & (K Units)
Table 40. APAC Hormonal Transdermal Patches Sales by Region (2018-2023) & (K Units)
Table 41. APAC Hormonal Transdermal Patches Sales Market Share by Region (2018-2023)
Table 42. APAC Hormonal Transdermal Patches Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Hormonal Transdermal Patches Revenue Market Share by Region (2018-2023)
Table 44. APAC Hormonal Transdermal Patches Sales by Type (2018-2023) & (K Units)
Table 45. APAC Hormonal Transdermal Patches Sales by Application (2018-2023) & (K Units)
Table 46. Europe Hormonal Transdermal Patches Sales by Country (2018-2023) & (K Units)
Table 47. Europe Hormonal Transdermal Patches Sales Market Share by Country (2018-2023)
Table 48. Europe Hormonal Transdermal Patches Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Hormonal Transdermal Patches Revenue Market Share by Country (2018-2023)
Table 50. Europe Hormonal Transdermal Patches Sales by Type (2018-2023) & (K Units)
Table 51. Europe Hormonal Transdermal Patches Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Hormonal Transdermal Patches Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Hormonal Transdermal Patches Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Hormonal Transdermal Patches Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Hormonal Transdermal Patches Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Hormonal Transdermal Patches Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Hormonal Transdermal Patches Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Hormonal Transdermal Patches
Table 59. Key Market Challenges & Risks of Hormonal Transdermal Patches
Table 60. Key Industry Trends of Hormonal Transdermal Patches
Table 61. Hormonal Transdermal Patches Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Hormonal Transdermal Patches Distributors List
Table 64. Hormonal Transdermal Patches Customer List
Table 65. Global Hormonal Transdermal Patches Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Hormonal Transdermal Patches Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Hormonal Transdermal Patches Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Hormonal Transdermal Patches Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Hormonal Transdermal Patches Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Hormonal Transdermal Patches Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Hormonal Transdermal Patches Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Hormonal Transdermal Patches Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Hormonal Transdermal Patches Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Hormonal Transdermal Patches Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Hormonal Transdermal Patches Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Hormonal Transdermal Patches Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Hormonal Transdermal Patches Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Hormonal Transdermal Patches Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Xulane Basic Information, Hormonal Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 80. Xulane Hormonal Transdermal Patches Product Portfolios and Specifications
Table 81. Xulane Hormonal Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Xulane Main Business
Table 83. Xulane Latest Developments
Table 84. Twirla Basic Information, Hormonal Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 85. Twirla Hormonal Transdermal Patches Product Portfolios and Specifications
Table 86. Twirla Hormonal Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Twirla Main Business
Table 88. Twirla Latest Developments
Table 89. Planned Parenthood Basic Information, Hormonal Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 90. Planned Parenthood Hormonal Transdermal Patches Product Portfolios and Specifications
Table 91. Planned Parenthood Hormonal Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Planned Parenthood Main Business
Table 93. Planned Parenthood Latest Developments
Table 94. Lvye Pharma Basic Information, Hormonal Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 95. Lvye Pharma Hormonal Transdermal Patches Product Portfolios and Specifications
Table 96. Lvye Pharma Hormonal Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Lvye Pharma Main Business
Table 98. Lvye Pharma Latest Developments
Table 99. Novartis Basic Information, Hormonal Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 100. Novartis Hormonal Transdermal Patches Product Portfolios and Specifications
Table 101. Novartis Hormonal Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Novartis Main Business
Table 103. Novartis Latest Developments
Table 104. Bayer Healthcare Pharmaceuticals Basic Information, Hormonal Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 105. Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Product Portfolios and Specifications
Table 106. Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Bayer Healthcare Pharmaceuticals Main Business
Table 108. Bayer Healthcare Pharmaceuticals Latest Developments
Table 109. Watson Labs Basic Information, Hormonal Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 110. Watson Labs Hormonal Transdermal Patches Product Portfolios and Specifications
Table 111. Watson Labs Hormonal Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Watson Labs Main Business
Table 113. Watson Labs Latest Developments
Table 114. Women First Healthcare Inc Basic Information, Hormonal Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 115. Women First Healthcare Inc Hormonal Transdermal Patches Product Portfolios and Specifications
Table 116. Women First Healthcare Inc Hormonal Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Women First Healthcare Inc Main Business
Table 118. Women First Healthcare Inc Latest Developments
Table 119. Noven Basic Information, Hormonal Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 120. Noven Hormonal Transdermal Patches Product Portfolios and Specifications
Table 121. Noven Hormonal Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Noven Main Business
Table 123. Noven Latest Developments
Table 124. AbbVie Basic Information, Hormonal Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 125. AbbVie Hormonal Transdermal Patches Product Portfolios and Specifications
Table 126. AbbVie Hormonal Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. AbbVie Main Business
Table 128. AbbVie Latest Developments
Table 129. Lumara Health Basic Information, Hormonal Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 130. Lumara Health Hormonal Transdermal Patches Product Portfolios and Specifications
Table 131. Lumara Health Hormonal Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Lumara Health Main Business
Table 133. Lumara Health Latest Developments
Table 134. ANI Pharmaceuticals Basic Information, Hormonal Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 135. ANI Pharmaceuticals Hormonal Transdermal Patches Product Portfolios and Specifications
Table 136. ANI Pharmaceuticals Hormonal Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. ANI Pharmaceuticals Main Business
Table 138. ANI Pharmaceuticals Latest Developments
Table 1. Hormonal Transdermal Patches Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Hormonal Transdermal Patches Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Contraceptive Patches
Table 4. Major Players of Estradiol Patches
Table 5. Major Players of Others
Table 6. Global Hormonal Transdermal Patches Sales by Type (2018-2023) & (K Units)
Table 7. Global Hormonal Transdermal Patches Sales Market Share by Type (2018-2023)
Table 8. Global Hormonal Transdermal Patches Revenue by Type (2018-2023) & ($ million)
Table 9. Global Hormonal Transdermal Patches Revenue Market Share by Type (2018-2023)
Table 10. Global Hormonal Transdermal Patches Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Hormonal Transdermal Patches Sales by Application (2018-2023) & (K Units)
Table 12. Global Hormonal Transdermal Patches Sales Market Share by Application (2018-2023)
Table 13. Global Hormonal Transdermal Patches Revenue by Application (2018-2023)
Table 14. Global Hormonal Transdermal Patches Revenue Market Share by Application (2018-2023)
Table 15. Global Hormonal Transdermal Patches Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Hormonal Transdermal Patches Sales by Company (2018-2023) & (K Units)
Table 17. Global Hormonal Transdermal Patches Sales Market Share by Company (2018-2023)
Table 18. Global Hormonal Transdermal Patches Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Hormonal Transdermal Patches Revenue Market Share by Company (2018-2023)
Table 20. Global Hormonal Transdermal Patches Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Hormonal Transdermal Patches Producing Area Distribution and Sales Area
Table 22. Players Hormonal Transdermal Patches Products Offered
Table 23. Hormonal Transdermal Patches Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Hormonal Transdermal Patches Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Hormonal Transdermal Patches Sales Market Share Geographic Region (2018-2023)
Table 28. Global Hormonal Transdermal Patches Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Hormonal Transdermal Patches Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Hormonal Transdermal Patches Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Hormonal Transdermal Patches Sales Market Share by Country/Region (2018-2023)
Table 32. Global Hormonal Transdermal Patches Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Hormonal Transdermal Patches Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Hormonal Transdermal Patches Sales by Country (2018-2023) & (K Units)
Table 35. Americas Hormonal Transdermal Patches Sales Market Share by Country (2018-2023)
Table 36. Americas Hormonal Transdermal Patches Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Hormonal Transdermal Patches Revenue Market Share by Country (2018-2023)
Table 38. Americas Hormonal Transdermal Patches Sales by Type (2018-2023) & (K Units)
Table 39. Americas Hormonal Transdermal Patches Sales by Application (2018-2023) & (K Units)
Table 40. APAC Hormonal Transdermal Patches Sales by Region (2018-2023) & (K Units)
Table 41. APAC Hormonal Transdermal Patches Sales Market Share by Region (2018-2023)
Table 42. APAC Hormonal Transdermal Patches Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Hormonal Transdermal Patches Revenue Market Share by Region (2018-2023)
Table 44. APAC Hormonal Transdermal Patches Sales by Type (2018-2023) & (K Units)
Table 45. APAC Hormonal Transdermal Patches Sales by Application (2018-2023) & (K Units)
Table 46. Europe Hormonal Transdermal Patches Sales by Country (2018-2023) & (K Units)
Table 47. Europe Hormonal Transdermal Patches Sales Market Share by Country (2018-2023)
Table 48. Europe Hormonal Transdermal Patches Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Hormonal Transdermal Patches Revenue Market Share by Country (2018-2023)
Table 50. Europe Hormonal Transdermal Patches Sales by Type (2018-2023) & (K Units)
Table 51. Europe Hormonal Transdermal Patches Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Hormonal Transdermal Patches Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Hormonal Transdermal Patches Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Hormonal Transdermal Patches Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Hormonal Transdermal Patches Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Hormonal Transdermal Patches Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Hormonal Transdermal Patches Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Hormonal Transdermal Patches
Table 59. Key Market Challenges & Risks of Hormonal Transdermal Patches
Table 60. Key Industry Trends of Hormonal Transdermal Patches
Table 61. Hormonal Transdermal Patches Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Hormonal Transdermal Patches Distributors List
Table 64. Hormonal Transdermal Patches Customer List
Table 65. Global Hormonal Transdermal Patches Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Hormonal Transdermal Patches Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Hormonal Transdermal Patches Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Hormonal Transdermal Patches Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Hormonal Transdermal Patches Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Hormonal Transdermal Patches Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Hormonal Transdermal Patches Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Hormonal Transdermal Patches Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Hormonal Transdermal Patches Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Hormonal Transdermal Patches Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Hormonal Transdermal Patches Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Hormonal Transdermal Patches Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Hormonal Transdermal Patches Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Hormonal Transdermal Patches Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Xulane Basic Information, Hormonal Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 80. Xulane Hormonal Transdermal Patches Product Portfolios and Specifications
Table 81. Xulane Hormonal Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Xulane Main Business
Table 83. Xulane Latest Developments
Table 84. Twirla Basic Information, Hormonal Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 85. Twirla Hormonal Transdermal Patches Product Portfolios and Specifications
Table 86. Twirla Hormonal Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Twirla Main Business
Table 88. Twirla Latest Developments
Table 89. Planned Parenthood Basic Information, Hormonal Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 90. Planned Parenthood Hormonal Transdermal Patches Product Portfolios and Specifications
Table 91. Planned Parenthood Hormonal Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Planned Parenthood Main Business
Table 93. Planned Parenthood Latest Developments
Table 94. Lvye Pharma Basic Information, Hormonal Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 95. Lvye Pharma Hormonal Transdermal Patches Product Portfolios and Specifications
Table 96. Lvye Pharma Hormonal Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Lvye Pharma Main Business
Table 98. Lvye Pharma Latest Developments
Table 99. Novartis Basic Information, Hormonal Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 100. Novartis Hormonal Transdermal Patches Product Portfolios and Specifications
Table 101. Novartis Hormonal Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Novartis Main Business
Table 103. Novartis Latest Developments
Table 104. Bayer Healthcare Pharmaceuticals Basic Information, Hormonal Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 105. Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Product Portfolios and Specifications
Table 106. Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Bayer Healthcare Pharmaceuticals Main Business
Table 108. Bayer Healthcare Pharmaceuticals Latest Developments
Table 109. Watson Labs Basic Information, Hormonal Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 110. Watson Labs Hormonal Transdermal Patches Product Portfolios and Specifications
Table 111. Watson Labs Hormonal Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Watson Labs Main Business
Table 113. Watson Labs Latest Developments
Table 114. Women First Healthcare Inc Basic Information, Hormonal Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 115. Women First Healthcare Inc Hormonal Transdermal Patches Product Portfolios and Specifications
Table 116. Women First Healthcare Inc Hormonal Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Women First Healthcare Inc Main Business
Table 118. Women First Healthcare Inc Latest Developments
Table 119. Noven Basic Information, Hormonal Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 120. Noven Hormonal Transdermal Patches Product Portfolios and Specifications
Table 121. Noven Hormonal Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Noven Main Business
Table 123. Noven Latest Developments
Table 124. AbbVie Basic Information, Hormonal Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 125. AbbVie Hormonal Transdermal Patches Product Portfolios and Specifications
Table 126. AbbVie Hormonal Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. AbbVie Main Business
Table 128. AbbVie Latest Developments
Table 129. Lumara Health Basic Information, Hormonal Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 130. Lumara Health Hormonal Transdermal Patches Product Portfolios and Specifications
Table 131. Lumara Health Hormonal Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Lumara Health Main Business
Table 133. Lumara Health Latest Developments
Table 134. ANI Pharmaceuticals Basic Information, Hormonal Transdermal Patches Manufacturing Base, Sales Area and Its Competitors
Table 135. ANI Pharmaceuticals Hormonal Transdermal Patches Product Portfolios and Specifications
Table 136. ANI Pharmaceuticals Hormonal Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. ANI Pharmaceuticals Main Business
Table 138. ANI Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Hormonal Transdermal Patches
Figure 2. Hormonal Transdermal Patches Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hormonal Transdermal Patches Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Hormonal Transdermal Patches Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Hormonal Transdermal Patches Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Contraceptive Patches
Figure 10. Product Picture of Estradiol Patches
Figure 11. Product Picture of Others
Figure 12. Global Hormonal Transdermal Patches Sales Market Share by Type in 2022
Figure 13. Global Hormonal Transdermal Patches Revenue Market Share by Type (2018-2023)
Figure 14. Hormonal Transdermal Patches Consumed in Hospital
Figure 15. Global Hormonal Transdermal Patches Market: Hospital (2018-2023) & (K Units)
Figure 16. Hormonal Transdermal Patches Consumed in Clinic
Figure 17. Global Hormonal Transdermal Patches Market: Clinic (2018-2023) & (K Units)
Figure 18. Global Hormonal Transdermal Patches Sales Market Share by Application (2022)
Figure 19. Global Hormonal Transdermal Patches Revenue Market Share by Application in 2022
Figure 20. Hormonal Transdermal Patches Sales Market by Company in 2022 (K Units)
Figure 21. Global Hormonal Transdermal Patches Sales Market Share by Company in 2022
Figure 22. Hormonal Transdermal Patches Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Hormonal Transdermal Patches Revenue Market Share by Company in 2022
Figure 24. Global Hormonal Transdermal Patches Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Hormonal Transdermal Patches Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Hormonal Transdermal Patches Sales 2018-2023 (K Units)
Figure 27. Americas Hormonal Transdermal Patches Revenue 2018-2023 ($ Millions)
Figure 28. APAC Hormonal Transdermal Patches Sales 2018-2023 (K Units)
Figure 29. APAC Hormonal Transdermal Patches Revenue 2018-2023 ($ Millions)
Figure 30. Europe Hormonal Transdermal Patches Sales 2018-2023 (K Units)
Figure 31. Europe Hormonal Transdermal Patches Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Hormonal Transdermal Patches Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Hormonal Transdermal Patches Revenue 2018-2023 ($ Millions)
Figure 34. Americas Hormonal Transdermal Patches Sales Market Share by Country in 2022
Figure 35. Americas Hormonal Transdermal Patches Revenue Market Share by Country in 2022
Figure 36. Americas Hormonal Transdermal Patches Sales Market Share by Type (2018-2023)
Figure 37. Americas Hormonal Transdermal Patches Sales Market Share by Application (2018-2023)
Figure 38. United States Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Hormonal Transdermal Patches Sales Market Share by Region in 2022
Figure 43. APAC Hormonal Transdermal Patches Revenue Market Share by Regions in 2022
Figure 44. APAC Hormonal Transdermal Patches Sales Market Share by Type (2018-2023)
Figure 45. APAC Hormonal Transdermal Patches Sales Market Share by Application (2018-2023)
Figure 46. China Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Hormonal Transdermal Patches Sales Market Share by Country in 2022
Figure 54. Europe Hormonal Transdermal Patches Revenue Market Share by Country in 2022
Figure 55. Europe Hormonal Transdermal Patches Sales Market Share by Type (2018-2023)
Figure 56. Europe Hormonal Transdermal Patches Sales Market Share by Application (2018-2023)
Figure 57. Germany Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Hormonal Transdermal Patches Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Hormonal Transdermal Patches Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Hormonal Transdermal Patches Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Hormonal Transdermal Patches Sales Market Share by Application (2018-2023)
Figure 66. Egypt Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Hormonal Transdermal Patches in 2022
Figure 72. Manufacturing Process Analysis of Hormonal Transdermal Patches
Figure 73. Industry Chain Structure of Hormonal Transdermal Patches
Figure 74. Channels of Distribution
Figure 75. Global Hormonal Transdermal Patches Sales Market Forecast by Region (2024-2029)
Figure 76. Global Hormonal Transdermal Patches Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Hormonal Transdermal Patches Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Hormonal Transdermal Patches Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Hormonal Transdermal Patches Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Hormonal Transdermal Patches Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Hormonal Transdermal Patches
Figure 2. Hormonal Transdermal Patches Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hormonal Transdermal Patches Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Hormonal Transdermal Patches Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Hormonal Transdermal Patches Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Contraceptive Patches
Figure 10. Product Picture of Estradiol Patches
Figure 11. Product Picture of Others
Figure 12. Global Hormonal Transdermal Patches Sales Market Share by Type in 2022
Figure 13. Global Hormonal Transdermal Patches Revenue Market Share by Type (2018-2023)
Figure 14. Hormonal Transdermal Patches Consumed in Hospital
Figure 15. Global Hormonal Transdermal Patches Market: Hospital (2018-2023) & (K Units)
Figure 16. Hormonal Transdermal Patches Consumed in Clinic
Figure 17. Global Hormonal Transdermal Patches Market: Clinic (2018-2023) & (K Units)
Figure 18. Global Hormonal Transdermal Patches Sales Market Share by Application (2022)
Figure 19. Global Hormonal Transdermal Patches Revenue Market Share by Application in 2022
Figure 20. Hormonal Transdermal Patches Sales Market by Company in 2022 (K Units)
Figure 21. Global Hormonal Transdermal Patches Sales Market Share by Company in 2022
Figure 22. Hormonal Transdermal Patches Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Hormonal Transdermal Patches Revenue Market Share by Company in 2022
Figure 24. Global Hormonal Transdermal Patches Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Hormonal Transdermal Patches Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Hormonal Transdermal Patches Sales 2018-2023 (K Units)
Figure 27. Americas Hormonal Transdermal Patches Revenue 2018-2023 ($ Millions)
Figure 28. APAC Hormonal Transdermal Patches Sales 2018-2023 (K Units)
Figure 29. APAC Hormonal Transdermal Patches Revenue 2018-2023 ($ Millions)
Figure 30. Europe Hormonal Transdermal Patches Sales 2018-2023 (K Units)
Figure 31. Europe Hormonal Transdermal Patches Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Hormonal Transdermal Patches Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Hormonal Transdermal Patches Revenue 2018-2023 ($ Millions)
Figure 34. Americas Hormonal Transdermal Patches Sales Market Share by Country in 2022
Figure 35. Americas Hormonal Transdermal Patches Revenue Market Share by Country in 2022
Figure 36. Americas Hormonal Transdermal Patches Sales Market Share by Type (2018-2023)
Figure 37. Americas Hormonal Transdermal Patches Sales Market Share by Application (2018-2023)
Figure 38. United States Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Hormonal Transdermal Patches Sales Market Share by Region in 2022
Figure 43. APAC Hormonal Transdermal Patches Revenue Market Share by Regions in 2022
Figure 44. APAC Hormonal Transdermal Patches Sales Market Share by Type (2018-2023)
Figure 45. APAC Hormonal Transdermal Patches Sales Market Share by Application (2018-2023)
Figure 46. China Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Hormonal Transdermal Patches Sales Market Share by Country in 2022
Figure 54. Europe Hormonal Transdermal Patches Revenue Market Share by Country in 2022
Figure 55. Europe Hormonal Transdermal Patches Sales Market Share by Type (2018-2023)
Figure 56. Europe Hormonal Transdermal Patches Sales Market Share by Application (2018-2023)
Figure 57. Germany Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Hormonal Transdermal Patches Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Hormonal Transdermal Patches Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Hormonal Transdermal Patches Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Hormonal Transdermal Patches Sales Market Share by Application (2018-2023)
Figure 66. Egypt Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Hormonal Transdermal Patches Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Hormonal Transdermal Patches in 2022
Figure 72. Manufacturing Process Analysis of Hormonal Transdermal Patches
Figure 73. Industry Chain Structure of Hormonal Transdermal Patches
Figure 74. Channels of Distribution
Figure 75. Global Hormonal Transdermal Patches Sales Market Forecast by Region (2024-2029)
Figure 76. Global Hormonal Transdermal Patches Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Hormonal Transdermal Patches Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Hormonal Transdermal Patches Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Hormonal Transdermal Patches Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Hormonal Transdermal Patches Revenue Market Share Forecast by Application (2024-2029)
